Sailon Pharmaceuticals disclosed in the Shenzhen Stock Exchange Interactive Exchange on January 17, 2020 that as of January 10, 2020, the number of shareholders of the company was 16,300, a decrease of 280 from the previous period (December 31, 2019). The margin is 1.68%.
The number of shareholders of Sailon Pharmaceuticals is lower than the market average. According to Choice data, as of January 10, 2020, the average number of shareholders of A-share listed companies was 48,600. Among all A-share listed companies, 26.29% have shareholders in the range of 20,000 to 35,000.
Number of shareholder accounts and stock price
Since December 10, 2018, the number of shareholder accounts of the company has declined for six consecutive periods, with a decrease of 28.25% so far. The stock price fell by 8.48% from December 10, 2018 to January 10, 2020.
Number of shareholders and share capital
As of January 10, 2020, the company's latest total share capital was 160 million shares, of which the circulating share capital was 59.838 million shares. The average number of circulating shares held by each household increased to 3,661 shares from 3,599 shares in the previous period, and the average circulating market value per household was 50,700 yuan.
Sailon Pharmaceuticals holdings have a circulating market value lower than the market average. According to Choice data, as of January 10, 2020, the average value of outstanding shares held by A-share listed companies per household was 378,900 yuan. Among all A-share listed companies, 41.40% of the company's households hold circulating stock market value in the range of 80,000 to 200,000.
Disclaimer: This article is based on big data production and is for reference only. It does not constitute any investment advice. Please operate at your own risk.
